The Europe Digestive Enzyme Supplements Market is expected to witness market growth of 7.0% CAGR during the forecast period (2022-2028).
The body cannot easily digest meals and absorb nutrients when the pancreas does not produce enough enzymes. The term for this is malabsorption. Nutritional shortages and painful signs including bloating, abdominal cramps, flatulence, and diarrhea can result from malabsorption. However, there are numerous more alleged uses for digestive enzyme supplements. They can aid those with cancer, autism, and even arthritis.
On prescription, digestive enzymes are accessible. They are also available as supplements over-the-counter (OTC). Supplements contain digestive enzymes from a variety of sources. These could consist of the pancreases of creatures, such as cows, pigs, or lambs. Other supplements for enzymes come from plants as well. For instance, pineapples are used to make bromelain. Papayas provide papain. Purified yeasts or fungi are the sources of lactase.
The geriatric population in the region is significantly rising. According to the Office of National Statistics, the UK population has been steadily aging throughout the second part of the 20th century, and future projections indicate that this trend will continue. In 2016, 11.8 million people in the UK were 65 or older, making up 18% of the country's overall population. In contrast, 9.1 million people made up 15.8% of the population 25 years earlier.
The Germany market dominated the Europe Digestive Enzyme Supplements Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $91.6 Million by 2028.The UK market is anticipated to grow at a CAGR of 6.1% during (2022 - 2028). Additionally, The France market is expected to exhibit a CAGR of 7.8% during (2022 - 2028).
Based on Application, the market is segmented into Additional supplements, Medical & Infant Nutrition and Sports Nutrition. Based on Origin, the market is segmented into Animal, Plant, Microbial and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ProThera, Inc., Enzymes, Inc., AST Enzymes, Vemo 99 Ltd., Zeus Biotech Pvt. Ltd., Metagenics, Inc., Xymogen, HVL, LLC, Ortho Molecular Products, Inc., and Enzymedica, Inc.
The body cannot easily digest meals and absorb nutrients when the pancreas does not produce enough enzymes. The term for this is malabsorption. Nutritional shortages and painful signs including bloating, abdominal cramps, flatulence, and diarrhea can result from malabsorption. However, there are numerous more alleged uses for digestive enzyme supplements. They can aid those with cancer, autism, and even arthritis.
On prescription, digestive enzymes are accessible. They are also available as supplements over-the-counter (OTC). Supplements contain digestive enzymes from a variety of sources. These could consist of the pancreases of creatures, such as cows, pigs, or lambs. Other supplements for enzymes come from plants as well. For instance, pineapples are used to make bromelain. Papayas provide papain. Purified yeasts or fungi are the sources of lactase.
The geriatric population in the region is significantly rising. According to the Office of National Statistics, the UK population has been steadily aging throughout the second part of the 20th century, and future projections indicate that this trend will continue. In 2016, 11.8 million people in the UK were 65 or older, making up 18% of the country's overall population. In contrast, 9.1 million people made up 15.8% of the population 25 years earlier.
The Germany market dominated the Europe Digestive Enzyme Supplements Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $91.6 Million by 2028.The UK market is anticipated to grow at a CAGR of 6.1% during (2022 - 2028). Additionally, The France market is expected to exhibit a CAGR of 7.8% during (2022 - 2028).
Based on Application, the market is segmented into Additional supplements, Medical & Infant Nutrition and Sports Nutrition. Based on Origin, the market is segmented into Animal, Plant, Microbial and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ProThera, Inc., Enzymes, Inc., AST Enzymes, Vemo 99 Ltd., Zeus Biotech Pvt. Ltd., Metagenics, Inc., Xymogen, HVL, LLC, Ortho Molecular Products, Inc., and Enzymedica, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Application- Additional supplements
- Medical & Infant Nutrition
- Sports Nutrition
- Animal
- Plant
- Microbial
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- ProThera, Inc.
- Enzymes, Inc.
- AST Enzymes
- Vemo 99 Ltd.
- Zeus Biotech Pvt. Ltd.
- Metagenics, Inc.
- Xymogen
- HVL, LLC
- Ortho Molecular Products, Inc.
- Enzymedica, Inc.
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Europe Digestive Enzyme Supplements Market by Application
Chapter 4. Europe Digestive Enzyme Supplements Market by Origin
Chapter 5. Europe Digestive Enzyme Supplements Market by Country
Chapter 6. Company Profiles
Companies Mentioned
- ProThera, Inc.
- Enzymes, Inc.
- AST Enzymes
- Vemo 99 Ltd.
- Zeus Biotech Pvt. Ltd.
- Metagenics, Inc.
- Xymogen
- HVL, LLC
- Ortho Molecular Products, Inc.
- Enzymedica, Inc.
Methodology
LOADING...
